• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验管理中的中央统计监测:一项范围综述。

Central statistical monitoring in clinical trial management: A scoping review.

作者信息

Fronc Maciej, Jakubczyk Michał, Love Sharon B, Talbot Susan, Rolfe Timothy

机构信息

Decision Analysis and Support Unit, Institute of Econometrics, SGH Warsaw School of Economics, Warsaw, Poland.

Central Monitoring and Data Analytics, GSK, Warsaw, Poland.

出版信息

Clin Trials. 2025 Jun;22(3):342-351. doi: 10.1177/17407745241304059. Epub 2025 Jan 2.

DOI:10.1177/17407745241304059
PMID:39744904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7617700/
Abstract

BACKGROUND

Clinical trials handle a huge amount of data which can be used during the trial to improve the ongoing study conduct. It is suggested by regulators to implement the remote approach to evaluate clinical trials by analysing collected data. Central statistical monitoring helps to achieve that by employing quantitative methods, the results of which are a basis for decision-making on quality issues.

METHODS

This article presents a scoping review which is based on a systematic and iterative approach to identify and synthesise literature on central statistical monitoring methodology. In particular, we investigated the decision-making processes (with emphasis on quality issues) of central statistical monitoring methodology and its place in the clinical trial workflow. We reviewed papers published over the last 10 years in two databases (Scopus and Web of Science) with a focus on data mining algorithms of central statistical monitoring and its benefit to the quality of trials.

RESULTS

As a result, 24 scientific papers were selected for this review, and they consider central statistical monitoring at two levels. First, the perspective of the central statistical monitoring process and its location in the study conduct in terms of quality issues. Second, central statistical monitoring methods categorised into practices applied in the industry, and innovative methods in development. The established methods are discussed through the prism of categories of their usage. In turn, the innovations refer to either research on new methods or extensions to existing ones.

DISCUSSION

Our review suggests directions for further research into central statistical monitoring methodology - including increased application of multivariate analysis and using advanced distance metrics - and guidance on how central statistical monitoring operates in response to regulators' requirements.

摘要

背景

临床试验处理大量数据,这些数据可在试验期间用于改进正在进行的研究。监管机构建议采用远程方法,通过分析收集的数据来评估临床试验。中央统计监测有助于通过采用定量方法来实现这一目标,其结果是质量问题决策的基础。

方法

本文提出了一项范围综述,该综述基于系统且迭代的方法来识别和综合关于中央统计监测方法的文献。特别是,我们研究了中央统计监测方法的决策过程(重点是质量问题)及其在临床试验工作流程中的位置。我们回顾了过去10年在两个数据库(Scopus和Web of Science)中发表的论文,重点关注中央统计监测的数据挖掘算法及其对试验质量的益处。

结果

结果,本综述选择了24篇科学论文,它们从两个层面考虑中央统计监测。首先,从中央统计监测过程及其在研究开展中就质量问题而言的位置的角度。其次,中央统计监测方法分为行业应用的实践方法和正在开发的创新方法。既定方法通过其使用类别的视角进行讨论。反过来,创新则涉及新方法的研究或对现有方法的扩展。

讨论

我们的综述提出了中央统计监测方法进一步研究的方向——包括增加多变量分析的应用和使用先进的距离度量——以及关于中央统计监测如何根据监管机构要求运作的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def0/7617700/611b7ec3034d/EMS205271-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def0/7617700/611b7ec3034d/EMS205271-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def0/7617700/611b7ec3034d/EMS205271-f001.jpg

相似文献

1
Central statistical monitoring in clinical trial management: A scoping review.临床试验管理中的中央统计监测:一项范围综述。
Clin Trials. 2025 Jun;22(3):342-351. doi: 10.1177/17407745241304059. Epub 2025 Jan 2.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs).制定基于证据的指南,用于在患者信息单页/说明书(PrinciPILs)中描述潜在益处和危害,这些信息单页既能提供信息又不会造成伤害。
Health Technol Assess. 2025 Aug;29(43):1-20. doi: 10.3310/GJJH2402.
5
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Monitoring strategies for clinical intervention studies.临床干预研究的监测策略。
Cochrane Database Syst Rev. 2021 Dec 8;12(12):MR000051. doi: 10.1002/14651858.MR000051.pub2.
8
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
9
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
10
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.

本文引用的文献

1
Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical Trials.中央统计监测能否提高数据质量?对159项临床试验中1111个研究点的分析
Ther Innov Regul Sci. 2024 May;58(3):483-494. doi: 10.1007/s43441-024-00613-w. Epub 2024 Feb 9.
2
Risk-Based Monitoring in Clinical Trials: 2021 Update.临床试验中的基于风险的监测:2021 更新。
Ther Innov Regul Sci. 2023 May;57(3):529-537. doi: 10.1007/s43441-022-00496-9. Epub 2023 Jan 9.
3
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes.
中央监测是否能提高质量?关键风险指标结果分析。
Ther Innov Regul Sci. 2023 Mar;57(2):295-303. doi: 10.1007/s43441-022-00470-5. Epub 2022 Oct 21.
4
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring.使用无监督统计监测检测临床试验中的欺诈行为。
Ther Innov Regul Sci. 2022 Jan;56(1):130-136. doi: 10.1007/s43441-021-00341-5. Epub 2021 Sep 29.
5
Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approach.多中心随机对照 SafeBoosC-III 试验中的中心数据监测——一种实用方法。
BMC Med Res Methodol. 2021 Jul 31;21(1):160. doi: 10.1186/s12874-021-01344-4.
6
Anomaly Detection Algorithm for Real-World Data and Evidence in Clinical Research: Implementation, Evaluation, and Validation Study.临床研究中真实世界数据和证据的异常检测算法:实施、评估与验证研究
JMIR Med Inform. 2021 May 7;9(5):e27172. doi: 10.2196/27172.
7
Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic.新冠疫情期间基于风险的临床试验集中式数据监测。
Contemp Clin Trials. 2021 May;104:106368. doi: 10.1016/j.cct.2021.106368. Epub 2021 Mar 26.
8
COVID-19-related medical research: a meta-research and critical appraisal.COVID-19 相关医学研究:元研究与批判性评价。
BMC Med Res Methodol. 2021 Jan 4;21(1):1. doi: 10.1186/s12874-020-01190-w.
9
Bayesian central statistical monitoring using finite mixture models in multicenter clinical trials.在多中心临床试验中使用有限混合模型的贝叶斯中央统计监测。
Contemp Clin Trials Commun. 2020 Apr 9;19:100566. doi: 10.1016/j.conctc.2020.100566. eCollection 2020 Sep.
10
Central statistical monitoring of investigator-led clinical trials in oncology.肿瘤学中研究者主导的临床试验的中央统计监测。
Int J Clin Oncol. 2020 Jul;25(7):1207-1214. doi: 10.1007/s10147-020-01726-6. Epub 2020 Jun 23.